Cargando…

Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China

Detalles Bibliográficos
Autores principales: Zhao, Liang, Du, Hongyao, Alamgir, Mahin, Yang, Jing, Miao, Xiaoping, Jiang, Biling, Xia, Yuting, Lou, Yuchen, Wang, Yujue, Shen, Chen, Zhu, Jinjin, Chung, Wen-Hung, Li, Yan, Tao, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Libbey Eurotext 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880659/
https://www.ncbi.nlm.nih.gov/pubmed/33459264
http://dx.doi.org/10.1684/ejd.2020.3908
_version_ 1783650741588590592
author Zhao, Liang
Du, Hongyao
Alamgir, Mahin
Yang, Jing
Miao, Xiaoping
Jiang, Biling
Xia, Yuting
Lou, Yuchen
Wang, Yujue
Shen, Chen
Zhu, Jinjin
Chung, Wen-Hung
Li, Yan
Tao, Juan
author_facet Zhao, Liang
Du, Hongyao
Alamgir, Mahin
Yang, Jing
Miao, Xiaoping
Jiang, Biling
Xia, Yuting
Lou, Yuchen
Wang, Yujue
Shen, Chen
Zhu, Jinjin
Chung, Wen-Hung
Li, Yan
Tao, Juan
author_sort Zhao, Liang
collection PubMed
description
format Online
Article
Text
id pubmed-7880659
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Libbey Eurotext
record_format MEDLINE/PubMed
spelling pubmed-78806592021-02-16 Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China Zhao, Liang Du, Hongyao Alamgir, Mahin Yang, Jing Miao, Xiaoping Jiang, Biling Xia, Yuting Lou, Yuchen Wang, Yujue Shen, Chen Zhu, Jinjin Chung, Wen-Hung Li, Yan Tao, Juan Eur J Dermatol Correspondence John Libbey Eurotext 2021-02-12 2020 /pmc/articles/PMC7880659/ /pubmed/33459264 http://dx.doi.org/10.1684/ejd.2020.3908 Text en © JLE/Springer 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Zhao, Liang
Du, Hongyao
Alamgir, Mahin
Yang, Jing
Miao, Xiaoping
Jiang, Biling
Xia, Yuting
Lou, Yuchen
Wang, Yujue
Shen, Chen
Zhu, Jinjin
Chung, Wen-Hung
Li, Yan
Tao, Juan
Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
title Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
title_full Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
title_fullStr Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
title_full_unstemmed Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
title_short Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
title_sort safety of biologics for psoriasis patients during the covid-19 pandemic: the experience from wuhan, china
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880659/
https://www.ncbi.nlm.nih.gov/pubmed/33459264
http://dx.doi.org/10.1684/ejd.2020.3908
work_keys_str_mv AT zhaoliang safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT duhongyao safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT alamgirmahin safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT yangjing safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT miaoxiaoping safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT jiangbiling safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT xiayuting safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT louyuchen safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT wangyujue safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT shenchen safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT zhujinjin safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT chungwenhung safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT liyan safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina
AT taojuan safetyofbiologicsforpsoriasispatientsduringthecovid19pandemictheexperiencefromwuhanchina